Natera Announces Publication of over 100 Peer-Reviewed Papers on SignateraTM [Yahoo! Finance]
Natera, Inc. (NTRA)
Last natera, inc. earnings: 2/26 04:10 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.natera.com
Company Research
Source: Yahoo! Finance
AUSTIN, Texas, November 21, 2024 BUSINESS WIRE Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that it has surpassed a key milestone with over 100 peer-reviewed publications on its personalized and tumor-informed molecular residual disease (MRD) test, Signatera. Multiple validation studies on Signatera have been published in top-tier journals like Nature Nature Medicine Nature Cancer Journal of Clinical Oncology Annals of Oncology, and JAMA Oncology . These include some of the largest and most comprehensive prospective studies of MRD testing to date. In clinical studies, Signatera continues to demonstrate excellent performance, and evidence-based use of Signatera in a real-world setting exemplifies its clinical utility and potential in guiding clinical care. These impactful studies have not only paved the way for coverage across a broad range of cancer types and indications but have also led to increased adoption among the medica
Show less
Read more
Impact Snapshot
Event Time:
NTRA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NTRA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NTRA alerts
High impacting Natera, Inc. news events
Weekly update
A roundup of the hottest topics
NTRA
News
- Natera Announces Publication of over 100 Peer-Reviewed Papers on SignateraTMBusiness Wire
- Natera, Inc. (NASDAQ: NTRA) had its price target raised by analysts at Piper Sandler from $150.00 to $200.00. They now have an "overweight" rating on the stock.MarketBeat
- Natera, Inc. (NASDAQ: NTRA) had its price target raised by analysts at Morgan Stanley from $132.00 to $176.00. They now have an "overweight" rating on the stock.MarketBeat
- Natera, Inc. (NASDAQ: NTRA) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.MarketBeat
- Natera, Inc. (NASDAQ: NTRA) had its price target raised by analysts at TD Cowen from $155.00 to $175.00. They now have a "buy" rating on the stock.MarketBeat
NTRA
Earnings
- 11/12/24 - Beat
NTRA
Sec Filings
- 11/21/24 - Form 4
- 11/19/24 - Form 144
- 11/15/24 - Form 4
- NTRA's page on the SEC website